Antiarrhythmic Agents. II. Therapeutic Considerations
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Advances in the management of digoxin toxicity in the older patient.
Borron S, Bismuth C, MUSZYNSKI J Drugs Aging. 1997; 10(1):18-33.
PMID: 9111705 DOI: 10.2165/00002512-199710010-00003.
Haemodynamic effects of the antiarrhythmic quaternary ammonium compound QX-572 in man.
Ryden L, Hjalmarson A , Kvasnicka J, Liander B Br Heart J. 1975; 37(1):65-73.
PMID: 1089426 PMC: 484155. DOI: 10.1136/hrt.37.1.65.
References
1.
Jelliffe R
. Administration of digoxin. Dis Chest. 1969; 56(1):56-60.
DOI: 10.1378/chest.56.1.56.
View
2.
Koch-Weser J, KLEIN S, Kastor J, DESANCTIS R
. Antiarrhythmic prophylaxis with procainamide in acute myocardial infarction. N Engl J Med. 1969; 281(23):1253-60.
DOI: 10.1056/NEJM196912042812301.
View
3.
Prindle Jr K, Skelton C, Epstein S, MARCUS F
. Influence of extracellular potassium concentration on myocardial uptake and inotropic effect of tritiated digoxin. Circ Res. 1971; 28(3):337-45.
DOI: 10.1161/01.res.28.3.337.
View
4.
Caldwell J, Greenberger N
. Interruption of the enterohepatic circulation of digitoxin by cholestyramine. I. Protection against lethal digitoxin intoxication. J Clin Invest. 1971; 50(12):2626-37.
PMC: 292212.
DOI: 10.1172/JCI106763.
View
5.
Elkins R, VASKO J, Morrow A
. Digitalis tolerance during atrial fibrillation and normal sinus rhythm. Am J Cardiol. 1967; 20(2):229-31.
DOI: 10.1016/0002-9149(67)90082-3.
View